Fidelity Contrafund
2
13M
2
0.11
1
- Areas of investment
Summary
In 2003 was created Fidelity Contrafund, which is appeared as VC. The company was established in North America in United States. The leading representative office of defined VC is situated in the Boston.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Heal, Fluidigm. Among the most popular fund investment industries, there are Personal Health, Health Care.
The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2011. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2009.
The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Fidelity Contrafund, startups are often financed by Versant Ventures, InterWest Partners, EuclidSR Partners. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Trans-Pacific Technology Fund (TPTF), Smallcap World Fund.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.11
- Investments by industry
- Genetics (1)
- Manufacturing (1)
- Life Science (1)
- Biotechnology (1)
- Apps (1) Show 4 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 100M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Heal | 22 May 2018 | Health Care, Health Diagnostics, Apps, Personal Health, Home Health Care | Late Stage Venture | 20M | United States, California, Los Angeles |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.